• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结合直肠黏液腺癌切除患者的肿瘤沉积物对早期复发进行精细化预测。

A refined prediction of early recurrence combining tumor deposits in patients with resected rectal mucinous adenocarcinoma.

机构信息

Department of Colorectal Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, People's Republic of China.

Department of Pathology, Fujian Medical University Union Hospital, Fuzhou, Fujian, People's Republic of China.

出版信息

Surg Today. 2023 Jul;53(7):762-772. doi: 10.1007/s00595-022-02613-5. Epub 2022 Nov 11.

DOI:10.1007/s00595-022-02613-5
PMID:36357597
Abstract

PURPOSE

Early recurrence (ER) of rectal mucinous adenocarcinoma (MAC) has yet to be defined. We therefore explored risk factors for ER and constructed a predictive nomogram.

METHOD

A total of 145 rectal MAC patients undergoing radical surgery were included. The minimum P value method was used to determine the optimal cut-off point to discriminate between ER and late recurrence (LR). Risk factors for ER were determined by a logistic regression analysis, and a predictive nomogram was constructed.

RESULTS

A total of 62 (42.8%) patients developed tumor recurrence. The optimal time to define ER was 12 months. A pre-treatment tumor distance from the anal verge ≤ 7 cm, pathological N stage, lymphovascular invasion, tumor deposits, and time to recurrence ≤ 12 months were significantly associated with a poor post-recurrence survival in patients with recurrence. A pre-treatment serum carcinoembryonic antigen (CEA) level > 10 ng/ml, pre-treatment tumor distance from the anal verge ≤ 7 cm, pathological N + stage, perineural invasion, and tumor deposits were identified as independent risk factors associated with ER. A nomogram predicting ER was constructed (C-index 0.870).

CONCLUSION

The pre-treatment serum CEA level, pre-treatment tumor distance from the anal verge, pathological N + stage, perineural invasion, and tumor deposits were significantly predictive of ER for rectal MAC patients.

摘要

目的

直肠黏液腺癌(MAC)的早期复发(ER)尚未得到明确界定。因此,我们探讨了 ER 的危险因素,并构建了一个预测列线图。

方法

共纳入 145 例接受根治性手术的直肠 MAC 患者。采用最小 P 值法确定区分 ER 和晚期复发(LR)的最佳截断值。通过 logistic 回归分析确定 ER 的危险因素,并构建预测列线图。

结果

共有 62 例(42.8%)患者发生肿瘤复发。定义 ER 的最佳时间为 12 个月。术前肿瘤距肛缘≤7cm、病理 N 分期、淋巴血管侵犯、肿瘤沉积物和复发时间≤12 个月与复发患者的预后生存不良显著相关。术前血清癌胚抗原(CEA)水平>10ng/ml、术前肿瘤距肛缘≤7cm、病理 N+分期、神经周围侵犯和肿瘤沉积物被确定为与 ER 相关的独立危险因素。构建了预测 ER 的列线图(C 指数 0.870)。

结论

术前血清 CEA 水平、术前肿瘤距肛缘的距离、病理 N+分期、神经周围侵犯和肿瘤沉积物是预测直肠 MAC 患者 ER 的显著预测因素。

相似文献

1
A refined prediction of early recurrence combining tumor deposits in patients with resected rectal mucinous adenocarcinoma.结合直肠黏液腺癌切除患者的肿瘤沉积物对早期复发进行精细化预测。
Surg Today. 2023 Jul;53(7):762-772. doi: 10.1007/s00595-022-02613-5. Epub 2022 Nov 11.
2
Defining and predicting early recurrence in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.定义并预测接受新辅助放化疗的局部晚期直肠癌患者的早期复发。
Eur J Surg Oncol. 2020 Nov;46(11):2057-2063. doi: 10.1016/j.ejso.2020.07.019. Epub 2020 Jul 25.
3
Development and validation of a prognostic nomogram for patients with stage II colon mucinous adenocarcinoma.开发并验证 II 期结肠黏液性腺癌患者的预后列线图。
Int J Colorectal Dis. 2022 Oct;37(10):2173-2184. doi: 10.1007/s00384-022-04251-2. Epub 2022 Sep 23.
4
Nomogram to predict disease recurrence in patients with locally advanced rectal cancer undergoing rectal surgery after neoadjuvant therapy: retrospective cohort study.列线图预测新辅助治疗后接受直肠手术的局部进展期直肠癌患者的疾病复发:回顾性队列研究。
BJS Open. 2022 Nov 2;6(6). doi: 10.1093/bjsopen/zrac138.
5
Survival after curative resection for stage I colorectal mucinous adenocarcinoma.Ⅰ期结直肠黏液腺癌根治性切除术后的生存情况。
BMC Gastroenterol. 2022 Apr 18;22(1):192. doi: 10.1186/s12876-022-02276-z.
6
Survival Benefits of Postoperative Chemotherapy in Patients With Colorectal Mucinous Adenocarcinoma: An Analysis Utilizing Propensity Score Matching From the Surveillance, Epidemiology, and End Results Database.术后化疗对结直肠黏液腺癌患者生存获益的影响:基于监测、流行病学和最终结果数据库的倾向评分匹配分析。
Am Surg. 2024 Nov;90(11):2969-2984. doi: 10.1177/00031348241257469. Epub 2024 Jun 7.
7
A nomogram for predicting cancer-specific survival in patients with rectal mucinous adenocarcinoma following surgery.一种用于预测直肠黏液腺癌患者术后癌症特异性生存的列线图。
Sci Rep. 2025 Feb 25;15(1):6809. doi: 10.1038/s41598-025-90428-y.
8
Prognostic factors affecting recurrence and survival in patients with locally advanced rectal cancer.影响局部晚期直肠癌患者复发和生存的预后因素。
J BUON. 2012 Apr-Jun;17(2):291-8.
9
Predictors of recurrence after local excision and postoperative chemoradiation therapy of adenocarcinoma of the rectum.直肠癌局部切除及术后放化疗后复发的预测因素
Ann Surg Oncol. 1999 Jan-Feb;6(1):26-32. doi: 10.1007/s10434-999-0026-3.
10
Prognosis Can Be Predicted More Accurately Using Pre- and Postchemoradiotherapy Carcinoembryonic Antigen Levels Compared to Only Prechemoradiotherapy Carcinoembryonic Antigen Level in Locally Advanced Rectal Cancer Patients Who Received Neoadjuvant Chemoradiotherapy.与仅使用新辅助放化疗的局部晚期直肠癌患者的放疗前癌胚抗原水平相比,联合使用放化疗前后的癌胚抗原水平能更准确地预测预后。
Medicine (Baltimore). 2016 Mar;95(10):e2965. doi: 10.1097/MD.0000000000002965.

引用本文的文献

1
A nomogram for predicting cancer-specific survival in patients with rectal mucinous adenocarcinoma following surgery.一种用于预测直肠黏液腺癌患者术后癌症特异性生存的列线图。
Sci Rep. 2025 Feb 25;15(1):6809. doi: 10.1038/s41598-025-90428-y.
2
A large population-based and validated study on the follow-up management and supportive strategy of locally advanced rectal cancer patients.一项基于大样本量的、经过验证的研究,旨在探讨局部进展期直肠癌患者的随访管理和支持性策略。
Support Care Cancer. 2024 Sep 11;32(10):652. doi: 10.1007/s00520-024-08860-1.

本文引用的文献

1
An Evidence-Based Guideline for Surveillance of Patients after Curative Treatment for Colon and Rectal Cancer.结直肠癌根治性治疗后患者监测的循证指南。
Curr Oncol. 2022 Jan 30;29(2):724-740. doi: 10.3390/curroncol29020062.
2
Combining tumor deposits with the number of lymph node metastases to improve the prognostic accuracy in stage III colon cancer: a post hoc analysis of the CALGB/SWOG 80702 phase III study (Alliance).将肿瘤沉积物与淋巴结转移数相结合,以提高 III 期结肠癌的预后准确性:CALGB/SWOG 80702 期 III 研究(Alliance)的事后分析。
Ann Oncol. 2021 Oct;32(10):1267-1275. doi: 10.1016/j.annonc.2021.07.009. Epub 2021 Jul 20.
3
The survival after recurrence of colorectal cancer: a retrospective study focused on time to recurrence after curative resection.
结直肠癌复发后的生存情况:一项侧重于根治性切除术后复发时间的回顾性研究。
Surg Today. 2022 Feb;52(2):239-250. doi: 10.1007/s00595-021-02336-z. Epub 2021 Jul 16.
4
Detection of asymptomatic recurrence improves survival of gastric cancer patients.无症状复发的检测可改善胃癌患者的生存。
Cancer Med. 2021 May;10(10):3249-3260. doi: 10.1002/cam4.3899. Epub 2021 May 1.
5
Predictors of early recurrence following neoadjuvant chemotherapy and surgical resection for localized pancreatic adenocarcinoma.局部胰腺腺癌新辅助化疗和手术切除后早期复发的预测因素。
J Surg Oncol. 2021 Sep;124(3):308-316. doi: 10.1002/jso.26510. Epub 2021 Apr 24.
6
Relationship Between Preoperative and Postoperative Serum Carcinoembryonic Antigen and Prognosis of Patients with Stage I-III Rectal Cancer: A Retrospective Study of a Multicentre Cohort of 1022 Rectal Cancer Patients.I-III期直肠癌患者术前和术后血清癌胚抗原与预后的关系:一项对1022例直肠癌患者多中心队列的回顾性研究
Cancer Manag Res. 2021 Mar 18;13:2643-2651. doi: 10.2147/CMAR.S290416. eCollection 2021.
7
Clinicopathological and Molecular Features of Colorectal Cancer Patients With Mucinous and Non-Mucinous Adenocarcinoma.黏液性和非黏液性腺癌结直肠癌患者的临床病理及分子特征
Front Oncol. 2021 Mar 2;11:620146. doi: 10.3389/fonc.2021.620146. eCollection 2021.
8
Influence of tumor location on short- and long-term outcomes after laparoscopic surgery for rectal cancer: a propensity score matched cohort study.肿瘤位置对腹腔镜直肠癌手术后短期和长期结局的影响:倾向评分匹配队列研究。
BMC Cancer. 2020 Aug 14;20(1):761. doi: 10.1186/s12885-020-07255-9.
9
Defining and predicting early recurrence in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.定义并预测接受新辅助放化疗的局部晚期直肠癌患者的早期复发。
Eur J Surg Oncol. 2020 Nov;46(11):2057-2063. doi: 10.1016/j.ejso.2020.07.019. Epub 2020 Jul 25.
10
Early recurrence after neoadjuvant chemoradiation therapy for locally advanced rectal cancer: Characteristics and risk factors.局部进展期直肠癌新辅助放化疗后早期复发:特征和危险因素。
Asian J Surg. 2021 Jan;44(1):298-302. doi: 10.1016/j.asjsur.2020.07.014. Epub 2020 Jul 25.